BridgeBio Pharma Inc (BBIO) — Capital Reinvestment Ratio

Latest as of June 2024: 0.03x

BridgeBio Pharma Inc (BBIO) has a Capital Reinvestment Ratio of 0.03x as of June 2024, meaning it reinvests 0% of its operating cash flow ($74.70 Million) in capital expenditures ($2.45 Million). See BBIO net asset quality score to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.03x

Capex / Operating Cash Flow

Operating Cash Flow

$74.70 Million

USD

Capital Expenditures

$2.45 Million

USD

Data as of

Jun 2024

Most recent filing

Annual Capital Reinvestment Ratio for BridgeBio Pharma Inc (None–None)

Year-by-year Capital Reinvestment Ratio for BridgeBio Pharma Inc from None to None. For live market cap and broader valuation context, see market value of BridgeBio Pharma Inc.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow